Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Inflammation Research
Erschienen in: Inflammation Research 12/2015

01.12.2015 | Original Research Paper

Association of interleukin-10 gene promoter polymorphism in spontaneous abortions: a family-based triad study

verfasst von: M. Vidyadhari, M. Sujatha, P. Krupa, A. Jyothy, Pratibha Nallari, A. Venkateshwari

Erschienen in: Inflammation Research | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

The present study is a triad study designed to determine the co-relation of IL-10 −819C/T promoter polymorphism with the risk of spontaneous abortions.

Materials

A total of 50 families with spontaneous abortions and 60 families with medically terminated pregnancies were considered for the present study. Fetal tissue of less than 20 weeks of gestation along with peripheral blood from all the couples was collected in this study.

Methods

A standard amplification refractory mutation system-polymerase chain reaction was carried out to determine the IL 10 genotype in all the subjects. Odd’s ratio and their respective 95 % confidence intervals were used to determine the strength of association between IL-10 promoter gene polymorphism and spontaneous abortions.

Results

The study revealed a statistically significant association of IL-10 −819C/T polymorphism between the two family groups among fetuses (p = 0.0000003) and mothers (p = 0.0000001). No significant difference was observed in the genotype distribution of IL-10 among fathers.

Conclusion

An increased frequency of TT genotype and T allele was observed in spontaneously aborted fetuses and their mothers compared to respective controls. In conclusion, IL-10 C −819T gene promoter polymorphism may act as a major genetic regulator in the etiology of spontaneous abortions.
Literatur
1.
Clark DA, Chaouat G. What do we know about spontaneous abortion mechanisms? Am J Reprod Immunol. 1989;19:28–37.CrossRefPubMed
2.
Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmun. 2003;20:281–5.CrossRefPubMed
3.
Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal–fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today. 1993;14:353–6.CrossRefPubMed
4.
Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today. 1997;18:478–82.CrossRefPubMed
5.
Kamali-Sarvestani E, Kiany S, Gharesi-Fard B, Robati M. Association study of IL-10 and IFN-gamma gene polymorphisms in Iranian women with preeclampsia. J Reprod Immunol. 2006;72:118–26.CrossRefPubMed
6.
Speer EM, Gentile DA, Zeevi A, Pillage G, Huo D, Skoner DP. Role of single nucleotide polymorphisms of cytokine genes in spontaneous preterm delivery. Hum Immunol. 2006;67:915–23.CrossRefPubMed
7.
Moura E, Mattar R, de Souza E, Torloni MR, Goncalves-Primo A, Daher S. Inflammatory cytokine gene polymorphisms and spontaneous preterm birth. J Reprod Immunol. 2009;80:115–21.CrossRefPubMed
8.
Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AI, Li TC. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update. 2003;9:163–74.CrossRefPubMed
9.
Bansal AS. Joining the immunological dots in recurrent miscarriage. Am J Reprod Immunol. 2010;64:307–15.PubMed
10.
Saini V, Arora S, Yadav A, Bhattacharjee J. Cytokines in recurrent pregnancy loss. Clin Chim Acta. 2011;412:702–8.CrossRefPubMed
11.
Choi YK, Kwak-Kim J. Cytokine gene polymorphisms in recurrent spontaneous abortions: a comprehensive review. Am J Reprod Immunol. 2008;60:91–110.CrossRefPubMed
12.
Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med. 1998;4:1020–4.CrossRefPubMed
13.
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnot PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10gene promoter. Eur J Immunogenet. 1997;24:1–8.CrossRefPubMed
14.
Qaddourah RH, Magdoud K, Saldanha FL, Mahmood N, Mustafa FE, Mahjoub T, Almawi WY. IL-10 gene promoter and intron polymorphisms and changes in IL-10 secretion in women with idiopathic recurrent miscarriage. Hum Reprod. 2014;1–10.
15.
Alkhuriji A, Alhimaidi A, Babay Z, Wary A. The relationship between cytokine gene polymorphism and unexplained recurrent spontaneous abortion in Saudi females. Saudi Med J. 2013;34:484–9.PubMed
16.
Blinn N, Stafford DW. Isolation of high molecular weight DNA from Eukaryotes. Nucleic Acids Res. 1976;3:2303–8.CrossRef
17.
Sowmya S, Ramaiah A, Sunitha T, Nallari P, Jyothy A, Venkateshwari A. Role of IL-10 −819 (C/T) promoter polymorphism in pre eclampsia. Inflammation. 2014;37:1022–7.
18.
Bombell S, McGuire W. Cytokine polymorphisms in women with recurrent pregnancy loss: meta-analysis. Aust N Z J Obstet Gynaecol. 2008;48:147–54.CrossRefPubMed
19.
Austgulen R, Lien E, Liabakk NB, Jacobsen G, Arntzen KJ. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 1994;57:149–55.CrossRefPubMed
20.
Von Wollf M, Thaler CJ, Strowitzki T, Broome J, Stolz W, Tabibzadeh S. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod. 2000;6:227–34.
21.
Hayakawa T, Takamura T, Hisada A, Abe T, Nomura G, Kobayashi K. IL-6 gene polymorphism -174G/C does not contribute substantially to hyperlipidaemia and Type II diabetes mellitus in Japanese men. Diabetologia. 2002;45:453–4.CrossRefPubMed
22.
Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol. 2001;13:219–28.CrossRefPubMed
23.
Slama R, Bouyer J, Windham G, Fenster L, Werwatz A, Swan SH. Influence of paternal age on the risk of spontaneous abortion. Am J Epidemiol. 2005;161:816–23.CrossRefPubMed
24.
25.
de La Rochebrochard E, Thonneau P. Paternal age and maternal age are risk factors for miscarriage; results of a multicentre Europeon study. Hum Reprod. 2002;17:1649–56.CrossRefPubMed
26.
Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester miscarriage—results from a UK-population-based case–control study. BJOG. 2007;114:170–86.CrossRefPubMed
27.
Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case ± control study. Hum Reprod. 2004;19:1644–6.CrossRefPubMed
28.
Gaskins AJ, Rich-Edwards JW, Hauser R, Williams PL, Gillman MW, Ginsburg ES, Missmer SA, Chavarro JE. Maternal prepregnancy folate intake and risk of spontaneous abortion and stillbirth. Obstet Gynecol. 2014;124(1):23–31.PubMedCentralCrossRefPubMed
29.
You SY, Kim JM, Lee KA, Park MH, Kim YJ, Chun SH. Association of preterm birth with IFN-γ, IL-10, and CYP 1A1 gene in Korean women. Korean J Obstet Gynecol. 2010;53:608–15.CrossRef
30.
Kamali-Sarvestani E, Zolghadri J, Gharesi-Fard B, Sarvari J. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women. J Reprod Immunol. 2005;65:171–8.CrossRefPubMed
31.
Prigoshin N, Tambutti M, Larriba J, Gogorza S, Testa R. Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol AJRI. 2004;52:36–41.CrossRefPubMed
32.
Bahadori M, Zarei S, Zarnani AH, Zarei O, Idali F, Hadavi R, Jeddi-Tehrani M. IL-6, IL-10 and IL-17 gene polymorphisms in Iranian women with recurrent miscarriage. Iran J Immunol. 2014;11:97–104.PubMed
33.
Radoi VE, Bohiltea CL, Bara C. Interleukin 10 gene polymorphisms and recurrent pregnancy loss in Romanian population. Hum Reprod. 2012;8:94–7.
34.
Bohiltea CL, Radoi VE. Interleukin-6 and interleukin-10 gene polymorphisms and recurrent pregnancy loss in Romanian population. Iran J Reprod Med. 2014;12:617–22.
35.
Parveen F, Shukla A, Agarwal S. Cytokine gene polymorphisms in northern Indian women with recurrent miscarriages. Fertil Steril. 2013;99:433–40.CrossRefPubMed
36.
Medica I, Ostojic S, Pereza N, Kastrin A, Peterlin B. Association between genetic polymorphisms in cytokine genes and recurrent miscarriage—a meta-analysis. Reprod Biomed. 2009;19:406–14.CrossRef
37.
Cochery-Nouvellon E, Nguyen P, Attaoua R, Cornillet-Lefebvre P, Mercier E, Vitry F, Gris JC. Interleukin 10 gene promoter polymorphisms in women with pregnancy loss: preferential association with embryonic wastage. Biol Reprod. 2009;80:1115–20.CrossRefPubMed
38.
Zammiti W, Mtiraoui N, Khairi H, Gris JC, Almawi WY, Manjoud T. Associations between tumor necrosis factor-alpha and lymphotoxin-alpha polymorphisms and idiopathic recurrent miscarriage. Reproduction. 2008;135:397–403.CrossRefPubMed
Metadaten
Titel
Association of interleukin-10 gene promoter polymorphism in spontaneous abortions: a family-based triad study
verfasst von
M. Vidyadhari
M. Sujatha
P. Krupa
A. Jyothy
Pratibha Nallari
A. Venkateshwari
Publikationsdatum
01.12.2015
Verlag
Springer Basel
Erschienen in
Inflammation Research / Ausgabe 12/2015
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-015-0879-9

Weitere Artikel der Ausgabe 12/2015

Inflammation Research 12/2015 Zur Ausgabe

Original Research Paper

Niclosamide inhibits the inflammatory and angiogenic activation of human umbilical vein endothelial cells

Original Research Paper

Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-κB activation

Original Research Paper

Anti-inflammatory effects of vicenin-2 and scolymoside in vitro and in vivo

Original Research Paper

Dual effects of a lectin from the green seaweed Caulerpa cupressoides var. lycopodium on inflammatory mediators in classical models of inflammation

Original Research Paper

Association between FCGR3B copy number variations and susceptibility to autoimmune diseases: a meta-analysis

Short Communication

Does occupational exposure to anesthetic gases lead to increase of pro-inflammatory cytokines?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise